allergy
Alpha-gal delayed IgE and immune-complex layer
Alpha-gal is the best anchor pathway for teaching how a glycan antigen can connect sensitization, delayed food kinetics, IgE-mediated mast-cell activation, cofactors, biologics/gelatin/medical products, and broader immune-complex handling.
Provenance layer
Pathway provenance context
Curated external IDs add pathway and protein context around Atlas content. They do not update the graph automatically and they are not patient-specific interpretation.
Review route
Move from public story to professional review.
Public mechanism
Delayed glycan-IgE story with explicit caveats.
Mast-cell node
Fc epsilon receptor threshold, alarmins, and mediator context.
IgE ratio
Read alpha-gal specific IgE against the total IgE background.
Response map
Professional state explorer for what rises, falls, or shifts.
Reasoning studio
Professional organizer for clues, uncertainties, and next questions.
Graph trace
Protected relationship traversal across Atlas nodes.
Pathway logic
Trigger to state transition
Alpha-gal should be interpreted as delayed glycan-specific IgE biology with immune-complex context, not as a simple immediate food-allergy pattern.
Entry triggers
Key signals
Labs and data
Visual sequence
sensitization
Tick-associated glycan sensitization
Tick exposure can create an anti-alpha-gal antibody response. The clinically distinctive state is anti-alpha-gal IgE with compatible delayed symptoms.
delay
Delayed antigen availability
Mammalian-derived lipids and glycolipids can change timing, so symptoms may occur hours after exposure rather than immediately.
effector
FcεRI mast-cell and basophil activation
Alpha-gal antigen can crosslink receptor-bound IgE on mast cells and basophils, releasing histamine and lipid mediators.
context
Cofactors and threshold shifts
Alcohol, exercise, NSAIDs, infection, sleep debt, stress, and mast-cell threshold can shift whether the same exposure becomes symptomatic.
Immune-complex layer
Antigen, antibody class, reader, and clearance context
The best-established clinical Alpha-gal syndrome mechanism is delayed IgE-mediated allergy; immune-complex biology is useful as a systems layer, not a replacement diagnosis.
Antigen form
Alpha-gal-bearing mammalian glycoproteins, glycolipids, gelatin, biologics, and selected medical-product exposures.
Antibody classes
IgE
IgG
IgM
IgA
Readers
FcεRI on mast cells/basophils
Fc gamma receptors
C1q/complement
macrophage clearance
liver and spleen filtering
Outcomes
mast-cell mediator symptoms
opsonization and clearance concepts
complement amplification if immune complexes persist
interpretive noise when non-IgE antibodies coexist
Cells
mast cells
basophils
B cells
plasma cells
macrophages
Tissues
gut
skin
vasculature
liver/spleen clearance systems
Caveats
Positive sensitization without compatible history can mislead.
Possible anaphylaxis is urgent.
This tool cannot determine food, biologic, medication, or medical-product safety.
Cross-links